Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

44.92
Delayed Data
As of Jul 01
 -0.07 / -0.16%
Today’s Change
30.13
Today|||52-Week Range
52.58
-11.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues41.9M41.7M32.1M47.7M
 
 
 
 
 
Depreciation And Amortization499.0K172.0K221.0K352.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses16.1M20.2M22.8M28.4M
 
 
 
 
 
Research And Development11.5M15.1M16.8M18.7M
 
 
 
 
 
Total Operating Expenses16.6M20.4M23.0M28.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income25.3M21.3M9.0M19.0M
 
 
 
 
 
Extraordinary Credit670.0K0.00----
 
 
Extraordinary Charge-686.0K-8.0K---166.0K
 
 
 
 
Interest Expense On Debt3.2M0.0031.0K18.0K
 
 
 
 
Other Expenses1.1M0.00381.0K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income23.3M21.4M9.6M19.3M
 
 
 
 
 
Income Taxes0.000.000.00-15.2M
 
 
Preferred Dividend0.000.00-2.5M0.00
 
 
Net Income1.6M1.4M-4.0M34.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS16.8M16.8M9.8M18.4M
 
 
 
 
 
Shares To Calculate EPS Diluted16.8M16.8M9.8M19.2M
 
 
 
 
 
 
Earnings Per ShareEPS$1.32$1.13-$0.67$1.80
 
 
 
 
 
EPS Diluted$0.15$0.17-$0.67$1.80
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account